Harvard Bioscience (NASDAQ:HBIO) Now Covered by StockNews.com

StockNews.com started coverage on shares of Harvard Bioscience (NASDAQ:HBIO – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Several other equities analysts have also recently weighed in on the company. Benchmark lowered their target price on Harvard Bioscience from […]